• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物-药物相互作用下的靶点介导药物处置,第二部分:竞争性和非竞争性情况。

Target mediated drug disposition with drug-drug interaction, Part II: competitive and uncompetitive cases.

作者信息

Koch Gilbert, Jusko William J, Schropp Johannes

机构信息

Pediatric Pharmacology and Pharmacometrics, University of Basel, Children's Hospital (UKBB), Spitalstrasse 33, 4056, Basel, Switzerland.

Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, NY, 14214, USA.

出版信息

J Pharmacokinet Pharmacodyn. 2017 Feb;44(1):27-42. doi: 10.1007/s10928-016-9502-0. Epub 2017 Jan 10.

DOI:10.1007/s10928-016-9502-0
PMID:28074396
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5470635/
Abstract

We present competitive and uncompetitive drug-drug interaction (DDI) with target mediated drug disposition (TMDD) equations and investigate their pharmacokinetic DDI properties. For application of TMDD models, quasi-equilibrium (QE) or quasi-steady state (QSS) approximations are necessary to reduce the number of parameters. To realize those approximations of DDI TMDD models, we derive an ordinary differential equation (ODE) representation formulated in free concentration and free receptor variables. This ODE formulation can be straightforward implemented in typical PKPD software without solving any non-linear equation system arising from the QE or QSS approximation of the rapid binding assumptions. This manuscript is the second in a series to introduce and investigate DDI TMDD models and to apply the QE or QSS approximation.

摘要

我们用目标介导的药物处置(TMDD)方程展示了竞争性和非竞争性药物-药物相互作用(DDI),并研究了它们的药代动力学DDI特性。对于TMDD模型的应用,需要准平衡(QE)或准稳态(QSS)近似来减少参数数量。为了实现DDI TMDD模型的这些近似,我们推导了一个以游离浓度和游离受体变量表示的常微分方程(ODE)。这种ODE公式可以直接在典型的PKPD软件中实现,而无需求解因快速结合假设的QE或QSS近似而产生的任何非线性方程组。本文是介绍和研究DDI TMDD模型以及应用QE或QSS近似的系列文章中的第二篇。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b24/5470635/83b30cad5373/nihms857228f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b24/5470635/6532daf0977f/nihms857228f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b24/5470635/84b3435f49ea/nihms857228f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b24/5470635/91bcad69dc73/nihms857228f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b24/5470635/83b30cad5373/nihms857228f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b24/5470635/6532daf0977f/nihms857228f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b24/5470635/84b3435f49ea/nihms857228f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b24/5470635/91bcad69dc73/nihms857228f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b24/5470635/83b30cad5373/nihms857228f4.jpg

相似文献

1
Target mediated drug disposition with drug-drug interaction, Part II: competitive and uncompetitive cases.药物-药物相互作用下的靶点介导药物处置,第二部分:竞争性和非竞争性情况。
J Pharmacokinet Pharmacodyn. 2017 Feb;44(1):27-42. doi: 10.1007/s10928-016-9502-0. Epub 2017 Jan 10.
2
Target-mediated drug disposition with drug-drug interaction, Part I: single drug case in alternative formulations.药物-药物相互作用下的靶点介导药物处置,第一部分:不同制剂中的单一药物情况
J Pharmacokinet Pharmacodyn. 2017 Feb;44(1):17-26. doi: 10.1007/s10928-016-9501-1. Epub 2017 Jan 10.
3
Target-mediated drug disposition model for drugs with two binding sites that bind to a target with one binding site.具有两个结合位点且其中一个结合位点与靶点结合的药物的靶点介导药物处置模型。
J Pharmacokinet Pharmacodyn. 2017 Oct;44(5):463-475. doi: 10.1007/s10928-017-9533-1. Epub 2017 Jul 19.
4
Approximations of the target-mediated drug disposition model and identifiability of model parameters.靶介导药物处置模型的近似值及模型参数的可识别性。
J Pharmacokinet Pharmacodyn. 2008 Oct;35(5):573-91. doi: 10.1007/s10928-008-9102-8. Epub 2008 Nov 13.
5
Target-mediated drug disposition model for drugs that bind to more than one target.针对与多个靶点结合的药物的基于靶点的药物处置模型。
J Pharmacokinet Pharmacodyn. 2010 Aug;37(4):323-46. doi: 10.1007/s10928-010-9163-3. Epub 2010 Jul 29.
6
Target-mediated drug disposition model for drugs with N > 2 binding sites that bind to a target with one binding site.具有 N > 2 个结合位点且与具有一个结合位点的靶标结合的药物的靶标介导的药物处置模型。
J Pharmacokinet Pharmacodyn. 2024 Dec;51(6):703-720. doi: 10.1007/s10928-024-09917-8. Epub 2024 Apr 19.
7
MPBPK-TMDD models for mAbs: alternative models, comparison, and identifiability issues.MPBPK-TMDD 模型用于单克隆抗体:替代模型、比较和可识别性问题。
J Pharmacokinet Pharmacodyn. 2018 Dec;45(6):787-802. doi: 10.1007/s10928-018-9608-7. Epub 2018 Nov 10.
8
Methods of solving rapid binding target-mediated drug disposition model for two drugs competing for the same receptor.解决两种药物竞争同一受体的快速结合靶介导药物处置模型的方法。
J Pharmacokinet Pharmacodyn. 2012 Oct;39(5):543-60. doi: 10.1007/s10928-012-9267-z. Epub 2012 Aug 29.
9
Target-mediated drug disposition model: approximations, identifiability of model parameters and applications to the population pharmacokinetic-pharmacodynamic modeling of biologics.靶向介导的药物处置模型:模型参数的近似值、可识别性及其在生物药剂学群体药代动力学-药效学建模中的应用。
Expert Opin Drug Metab Toxicol. 2009 Jul;5(7):803-12. doi: 10.1517/17425250902992901.
10
Dynamics of target-mediated drug disposition.靶介导药物处置动力学。
Eur J Pharm Sci. 2009 Dec 8;38(5):445-64. doi: 10.1016/j.ejps.2009.09.007. Epub 2009 Sep 26.

引用本文的文献

1
Low-dimensional neural ODEs and their application in pharmacokinetics.低维神经 ODE 及其在药代动力学中的应用。
J Pharmacokinet Pharmacodyn. 2024 Apr;51(2):123-140. doi: 10.1007/s10928-023-09886-4. Epub 2023 Oct 14.
2
Population pharmacokinetics and covariate analysis of Sym004, an antibody mixture against the epidermal growth factor receptor, in subjects with metastatic colorectal cancer and other solid tumors.针对转移性结直肠癌和其他实体瘤患者的表皮生长因子受体抗体混合物 Sym004 的群体药代动力学和协变量分析。
J Pharmacokinet Pharmacodyn. 2020 Feb;47(1):5-18. doi: 10.1007/s10928-019-09663-2. Epub 2019 Nov 2.
3

本文引用的文献

1
Target-mediated drug disposition with drug-drug interaction, Part I: single drug case in alternative formulations.药物-药物相互作用下的靶点介导药物处置,第一部分:不同制剂中的单一药物情况
J Pharmacokinet Pharmacodyn. 2017 Feb;44(1):17-26. doi: 10.1007/s10928-016-9501-1. Epub 2017 Jan 10.
2
Assessment of non-linear combination effect terms for drug-drug interactions.药物相互作用的非线性组合效应项评估。
J Pharmacokinet Pharmacodyn. 2016 Oct;43(5):461-79. doi: 10.1007/s10928-016-9490-0. Epub 2016 Sep 16.
3
Methods of solving rapid binding target-mediated drug disposition model for two drugs competing for the same receptor.
Target-Mediated Drug Disposition Model for Bispecific Antibodies: Properties, Approximation, and Optimal Dosing Strategy.
双特异性抗体的靶向介导药物处置模型:性质、逼近和最佳给药策略。
CPT Pharmacometrics Syst Pharmacol. 2019 Mar;8(3):177-187. doi: 10.1002/psp4.12369. Epub 2019 Jan 8.
4
New Equilibrium Models of Drug-Receptor Interactions Derived from Target-Mediated Drug Disposition.从基于靶点的药物处置推导的药物-受体相互作用的新平衡模型。
AAPS J. 2018 May 14;20(4):69. doi: 10.1208/s12248-018-0221-x.
5
Asymptotic analysis of a TMDD model: when a reaction contributes to the destruction of its product.一个TMDD模型的渐近分析:当一个反应导致其产物的破坏时。
J Math Biol. 2018 Sep;77(3):821-855. doi: 10.1007/s00285-018-1234-x. Epub 2018 Apr 19.
6
Target-mediated drug disposition with drug-drug interaction, Part I: single drug case in alternative formulations.药物-药物相互作用下的靶点介导药物处置,第一部分:不同制剂中的单一药物情况
J Pharmacokinet Pharmacodyn. 2017 Feb;44(1):17-26. doi: 10.1007/s10928-016-9501-1. Epub 2017 Jan 10.
解决两种药物竞争同一受体的快速结合靶介导药物处置模型的方法。
J Pharmacokinet Pharmacodyn. 2012 Oct;39(5):543-60. doi: 10.1007/s10928-012-9267-z. Epub 2012 Aug 29.
4
Dynamics of target-mediated drug disposition: characteristic profiles and parameter identification.靶向介导药物处置动力学:特征谱和参数辨识。
J Pharmacokinet Pharmacodyn. 2012 Oct;39(5):429-51. doi: 10.1007/s10928-012-9260-6. Epub 2012 Aug 1.
5
Approximations of the target-mediated drug disposition model and identifiability of model parameters.靶介导药物处置模型的近似值及模型参数的可识别性。
J Pharmacokinet Pharmacodyn. 2008 Oct;35(5):573-91. doi: 10.1007/s10928-008-9102-8. Epub 2008 Nov 13.
6
Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond.通过NMDA受体阻断实现神经保护的范式转变:美金刚及其他。
Nat Rev Drug Discov. 2006 Feb;5(2):160-70. doi: 10.1038/nrd1958.
7
Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists.药物研发中酶抑制剂的评估。给药物化学家与药理学家的指南。
Methods Biochem Anal. 2005;46:1-265.
8
Quasi-equilibrium pharmacokinetic model for drugs exhibiting target-mediated drug disposition.用于表现出靶点介导药物处置的药物的准平衡药代动力学模型。
Pharm Res. 2005 Oct;22(10):1589-96. doi: 10.1007/s11095-005-6650-0. Epub 2005 Sep 22.
9
Affinity, intrinsic activity and drug interactions.亲和力、内在活性与药物相互作用。
Pharmacol Rev. 1957 Jun;9(2):218-36.
10
General pharmacokinetic model for drugs exhibiting target-mediated drug disposition.表现出靶点介导药物处置的药物的一般药代动力学模型。
J Pharmacokinet Pharmacodyn. 2001 Dec;28(6):507-32. doi: 10.1023/a:1014414520282.